These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14555546)

  • 21. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of inhaled corticosteroids during childhood: plus ça change..
    Russell G
    Arch Dis Child; 2004 Oct; 89(10):893-5. PubMed ID: 15383426
    [No Abstract]   [Full Text] [Related]  

  • 23. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial.
    Rand C; Bilderback A; Schiller K; Edelman JM; Hustad CM; Zeiger RS;
    J Allergy Clin Immunol; 2007 Apr; 119(4):916-23. PubMed ID: 17349681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the administration time effect on the cumulative cortisol suppression and cumulative lymphocytes suppression for once-daily inhaled corticosteroids: a population modeling/simulation approach.
    Wu K; Goyal N; Stark JG; Hochhaus G
    J Clin Pharmacol; 2008 Sep; 48(9):1069-80. PubMed ID: 18728243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
    O'Connor RD; Stanford R; Crim C; Yancey SW; Edwards L; Rickard KA; Dorinsky P
    Ann Allergy Asthma Immunol; 2004 Dec; 93(6):581-8. PubMed ID: 15609769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maintenance asthma treatment with fluticasone/salmeterol combination via Diskus: effect on outcomes in inner-city children enrolled in TennCare.
    Nguyen WT; Stewart C; Fisher K; Tolley E; Lew DB; Self TH
    Allergy Asthma Proc; 2005; 26(2):129-34. PubMed ID: 15971472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma.
    O'Byrne PM; Jacques L; Goldfrad C; Kwon N; Perrio M; Yates LJ; Busse WW
    Respir Res; 2016 Nov; 17(1):157. PubMed ID: 27881132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.
    Gustafsson P; Tsanakas J; Gold M; Primhak R; Radford M; Gillies E
    Arch Dis Child; 1993 Aug; 69(2):206-11. PubMed ID: 8215522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unified disease, unified management: treating allergic rhinitis and asthma with nasally inhaled corticosteroid.
    Ribeiro de Andrade C; Chatkin JM; Fiterman J; Scaglia N; Camargos PA
    Respir Med; 2010 Oct; 104(10):1577-80. PubMed ID: 20637586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged protection of the new inhaled corticosteroid fluticasone furoate against AMP hyperresponsiveness in patients with asthma.
    van den Berge M; Luijk B; Bareille P; Dallow N; Postma DS; Lammers JW
    Allergy; 2010 Dec; 65(12):1531-5. PubMed ID: 20560909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma.
    Jarvis B; Faulds D
    Drugs; 1999 May; 57(5):769-803. PubMed ID: 10353302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of once- with twice-daily dosing of fluticasone propionate in mild and moderate asthma.
    Boulet LP; Cowie RL; Negro RD; Brett W; Gold M; Marques A; Thorburn WS; Stepner NM; Robson R
    Can Respir J; 2000; 7(3):239-47. PubMed ID: 10903487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid onset of iatrogenic adrenal insufficiency in a patient with cystic fibrosis-related liver disease treated with inhaled corticosteroids and a moderate CYP3A4 inhibitor.
    Hoover WC; Britton LJ; Gardner J; Jackson T; Gutierrez H
    Ann Pharmacother; 2011 Jul; 45(7-8):e38. PubMed ID: 21712512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhaled corticosteroids and adrenal function.
    Romney J
    Ann Intern Med; 2004 Oct; 141(8):W123; author reply W123. PubMed ID: 15492336
    [No Abstract]   [Full Text] [Related]  

  • 35. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial.
    Rowe BH; Wong E; Blitz S; Diner B; Mackey D; Ross S; Senthilselvan A
    Acad Emerg Med; 2007 Oct; 14(10):833-40. PubMed ID: 17898245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED).
    Gappa M; Zachgo W; von Berg A; Kamin W; Stern-Sträter C; Steinkamp G;
    Pediatr Pulmonol; 2009 Nov; 44(11):1132-42. PubMed ID: 19824054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ciclesonide versus other inhaled corticosteroids for chronic asthma in children.
    Kramer S; Rottier BL; Scholten RJ; Boluyt N
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD010352. PubMed ID: 23450613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of a more favourable response to combined therapy with salmeterol and fluticasone as initial maintenance therapy in asthma.
    Ernst P; Franssen E; Chan CK; Okell M; O'Byrne P; Bai T
    Respir Med; 2008 Jan; 102(1):77-81. PubMed ID: 17904834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma.
    Nathan RA; Li JT; Finn A; Jones R; Payne JE; Wolford JP; Harding SM
    Chest; 2000 Aug; 118(2):296-302. PubMed ID: 10936116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The dull-edged sword of inhaled corticosteroids.
    Harding SM
    Chest; 1999 Oct; 116(4):854-6. PubMed ID: 10531140
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.